Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Mohammed Haidar Hazaa Al-Dholae, Mohammed Kassim Salah, Omar Yahya Al-Ashmali, Abdul Salam Mohamed Al Mokdad & Mohammed Ali Al-Madwami. (2023) Thrombocytopenia (TCP), MELD Score, and Fibrosis Index (FI) Among Hospitalized Patients with Chronic Liver Disease (CLD) in Ma’abar City, Dhamar Governorate, Yemen: A Cross-Sectional Study. Hepatic Medicine: Evidence and Research 15, pages 43-50.
Read now
Read now
Yuki Ong, Cheong Wei Terence Huey & Vishalkumar Girishchandra Shelat. (2022) Paraneoplastic syndromes in hepatocellular carcinoma: a review. Expert Review of Gastroenterology & Hepatology 16:5, pages 449-471.
Read now
Read now
Katsuaki Tanaka, Takamichi Baba, Manami Yoshida, Motofumi Iguchi, Takuhiro Sonoyama, Takahiro Fukuhara & Takeshi Kano. (2022) Relationship between baseline clinical characteristics and efficacy of lusutrombopag in thrombocytopenic patients with chronic liver disease: post hoc analysis of two placebo-controlled phase 3 trials. Current Medical Research and Opinion 38:2, pages 303-310.
Read now
Read now
Ingrid Lindquist, Sven R. Olson, Ang Li, Hanny Al‐Samkari, Janice H. Jou, Owen J. T. McCarty & Joseph J. Shatzel. (2022) The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis. Platelets 33:1, pages 66-72.
Read now
Read now
Samuel H Sigal, Zachary Sherman & Arun Jesudian. (2020) Clinical Implications of Thrombocytopenia for the Cirrhotic Patient. Hepatic Medicine: Evidence and Research 12, pages 49-60.
Read now
Read now
Fiona Swain & Robert Bird. (2020) How I approach new onset thrombocytopenia. Platelets 31:3, pages 285-290.
Read now
Read now
Rianne A. Weersink, David M. Burger, Kelly L. Hayward, Katja Taxis, Joost P.H. Drenth & Sander D. Borgsteede. (2020) Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations. Expert Opinion on Drug Metabolism & Toxicology 16:1, pages 45-57.
Read now
Read now
Gerasimos P. Milas, Vasilios Karageorgiou & Evangelos Cholongitas. (2019) Red cell distribution width to platelet ratio for liver fibrosis: a systematic review and meta-analysis of diagnostic accuracy. Expert Review of Gastroenterology & Hepatology 13:9, pages 877-891.
Read now
Read now
Articles from other publishers (42)
Elvina C Lingas. (2023) Hematological Abnormalities in Cirrhosis: A Narrative Review. Cureus.
Crossref
Crossref
KANNAN NARAYANAN, SUE ANN ZACHARIAH & SHEELA KURIAN V. (2023) ASPARTATE PLATELET RATIO INDEX AS A PREDICTOR OF SEVERITY OF FIBROSIS IN CHRONIC HEPATITS C. Asian Journal of Pharmaceutical and Clinical Research, pages 69-83.
Crossref
Crossref
Sahil Kataria, Deven Juneja & Omender Singh. (2023) Approach to thromboelastography-based transfusion in cirrhosis: An alternative perspective on coagulation disorders. World Journal of Gastroenterology 29:9, pages 1460-1474.
Crossref
Crossref
Joanna R. Rock, Cynthia A. Kos, Anthony Lemaire, Hirohisa Ikegami, Mark J. Russo, Danyaal Moin, Kenneth Dulnuan & Deepa Iyer. (2022) Single center first year experience and outcomes with Impella 5.5 left ventricular assist device. Journal of Cardiothoracic Surgery 17:1.
Crossref
Crossref
M. I. Airapetov, S. O. Eresko, E. R. Bychkov, A. A. Lebedev & P. D. Shabanov. (2022) Effect of Ethanol on Platelet Biology. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 16:4, pages 305-317.
Crossref
Crossref
Marcus M. Mücke, Tony Bruns, Ali Canbay, Axel Matzdorff, Frank Tacke, Andreas Tiede, Jonel Trebicka, Heiner Wedemeyer, Kai Zacharowski, Stefan Zeuzem & Christian M. Lange. (2022) Einsatz von Thrombopoetin-Rezeptor-Agonisten (TPO-RA) vor invasiven Eingriffen bei Patienten mit Leberzirrhose. Zeitschrift für Gastroenterologie.
Crossref
Crossref
Ao Huang, Jia-Feng Chen, Jian-Zhang Wu, Zheng Gao, Ying-Hong Shi, Xiu-Tao Fu, Xin Zhang, Wei-Ren Liu, Qiang Gao, Hui-Chuan Sun, Guo-Ming Shi, Jia Fan, Zhen-Bin Ding & Jian Zhou. (2022) Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and Challenges. Journal of Oncology 2022, pages 1-11.
Crossref
Crossref
Mattia Brigida, Simona Di Caro, Carmine Petruzziello, Angela Saviano, Maria Elena Riccioni, Francesco Franceschi & Veronica Ojetti. (2022) Vitamin-K Antagonists vs. Direct Oral Anticoagulants on Severity of Upper Gastrointestinal Bleeding: A Retrospective Analysis of Italian and UK Data. Journal of Clinical Medicine 11:21, pages 6382.
Crossref
Crossref
Yong-Shuai Wang, Wei Wang, Sai Zhang, Shen-Yu Zhang, Ai-Zong Shen, Wei Wang, Hua-Chuan Song, Huan-Zhang Yao, Rui-Peng Song, Fan-Zheng Meng, Lei Li, Bjoern Nashan, Ji-Zhou Wang & Lian-Xin Liu. (2022) Clinical efficacy of avatrombopag and recombinant human thrombopoietin in the treatment of chronic liver disease-associated severe thrombocytopenia: A real-world study. Frontiers in Pharmacology 13.
Crossref
Crossref
Paolo Gallo, Francesca Terracciani, Giulia Di Pasquale, Matteo Esposito, Antonio Picardi & Umberto Vespasiani-Gentilucci. (2022) Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures. World Journal of Gastroenterology 28:30, pages 4061-4074.
Crossref
Crossref
Tyler C. Haddad, Songzhu Zhao, Mingjia Li, Sandip H. Patel, Andrew Johns, Madison Grogan, Gabriella Lopez, Abdul Miah, Lai Wei, Gabriel Tinoco, Brian Riesenberg, Zihai Li, Alexa Meara, Erin M. Bertino, Kari Kendra, Gregory Otterson, Carolyn J. Presley & Dwight H. Owen. (2021) Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival. Cancer Immunology, Immunotherapy 71:5, pages 1157-1165.
Crossref
Crossref
Jung Hee Kim, Sung-Eun Kim, Do-Seon Song, Hee-Yeon Kim, Eileen Yoon, Tae-Hyung Kim, Young-Kul Jung, Ki Tae Suk, Baek-Gyu Jun, Hyung-Joon Yim, Jung-Hyun Kwon, Sung-Won Lee, Seong-Hee Kang, Moon-Young Kim, Soung-Won Jeong, Jae-Young Jang, Jeong-Ju Yoo, Sang-Gyune Kim, Young-Joo Jin, Gab-Jin Cheon, Byung-Seok Kim, Yeon Seok Seo, Hyung-Su Kim, Dong-Hyun Sinn, Woo-Jin Chung, Hwi Young Kim, Han Ah Lee, Seung-Woo Nam, In-Hee Kim, Jung-Il Suh, Ji-Hoon Kim, Hee-Bok Chae, Joo-Hyun Sohn, Ju-Yeon Cho, Yoon-Jun Kim, Jin-Mo Yang, Jung-Gil Park, Won Kim, Hyun-Chin Cho & Dong Joon Kim. (2022) Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute Deterioration. Journal of Clinical Medicine 11:9, pages 2463.
Crossref
Crossref
Fahri Ahmad Baihaqi & Dinda Olinda Delarosa. (2022) Correlation between Platelet Count and Grading of Esophageal Varices in Liver Cirrhosis Patients: A Meta-Analysis. Open Access Macedonian Journal of Medical Sciences 10:F, pages 513-521.
Crossref
Crossref
M.I. Airapetov, S.O. Eresko, E.R. Bychkov, A.A. Lebedev & P.D. Shabanov. (2022) Effect of ethanol on platelet biology. Biomeditsinskaya Khimiya 68:2, pages 81-92.
Crossref
Crossref
Sahar Keshvari, Berit Genz, Ngari Teakle, Melanie Caruso, Michelle F. Cestari, Omkar L. Patkar, Brian W. C. Tse, Kamil A. Sokolowski, Hilmar Ebersbach, Julia Jascur, Kelli P. A. MacDonald, Gregory Miller, Grant A. Ramm, Allison R. Pettit, Andrew D. Clouston, Elizabeth E. Powell, David A. Hume & Katharine M. Irvine. (2022) Therapeutic potential of macrophage colony-stimulating factor in chronic liver disease. Disease Models & Mechanisms 15:4.
Crossref
Crossref
Derouiche Samir, Hammadi Nour & Chouia Maroua. (2022) Assessment of Haematological Complications and Prognostic Value of Oxidative Stress Markers in Viral Hepatitis B Patients. Journal of Medical Sciences 22:2, pages 44-52.
Crossref
Crossref
S. RaasiDr.Dr., K. NarayanasamyDr.Dr. & O. S. ArthyDr.Dr.. (2022) ASSESSMENT OF BASIC HEMATOLOGICAL CHANGES AND CLINICAL SEVERITY IN CHRONIC LIVER DISEASE WITH PERIPHERAL BLOOD NEUTROPHIL LYMPHOCYTE RATIO.. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 54-56.
Crossref
Crossref
Xiang Xu, Chen Li, Jing Chen, Xiaoyan Liu, Haibin Su, Jingjing Tong & Jinhua Hu. (2021) Relationship Between Platelet to White Blood Cell Ratio and 30-Day Prognosis of Patients with Acute-on-Chronic Liver Failure. Hepatitis Monthly 21:9.
Crossref
Crossref
Robert Flisiak, Krasimir Antonov, Pavel Drastich, Peter Jarcuska, Marina Maevskaya, Mihály Makara, Željko Puljiz, Borut Štabuc & Anca Trifan. (2021) Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasive Procedures. Journal of Clinical Medicine 10:22, pages 5419.
Crossref
Crossref
Subhashis ChakrabortyDr.Dr. & Debarshi JanaDr.Dr.. (2021) ASSOCIATION THROMBOCYTOPENIAAND ITS CO-RELATION IN CHRONIC LIVER DISEASE PATIENTS IN A TERTIARY CARE HOSPITAL. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 24-26.
Crossref
Crossref
Micheli Zanetti, Mikaela Scatolin, Amanda Rebonatto Oltramari, Maria Luiza Lima da Costa Lopes, Rubieli Carla Frezza Zeferino, Gustavo Lopes Colpani, Liz Girardi Müller, Débora de Oliveira & Marcio Antônio Fiori. (2021) Antifungal Activity and Acute and Repeated-Dose Toxicity Study of Geranyl Cinnamate Ester in Mice. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-14.
Crossref
Crossref
Preeti Kanikarla Marie, Natalie W. Fowlkes, Vahid Afshar-Kharghan, Stephanie L. Martch, Alexey Sorokin, John Paul Shen, Van K. Morris, Arvind Dasari, Nancy You, Anil K. Sood, Michael J. Overman, Scott Kopetz & David George Menter. (2021) The Provocative Roles of Platelets in Liver Disease and Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Shreya Desai & Anita Subramanian. (2021) Thrombocytopenia in Chronic Liver Disease: Challenges and Treatment Strategies. Cureus.
Crossref
Crossref
Kavita Gaur, Vandana Puri, Kiran Agarwal, Santosh Suman & Rajinder K Dhamija. (2021) Chronic Liver Disease Presenting as Immune Hemolytic Anemia: The Challenges of Diagnosis in the Critically Ill in a Resource-Limited Health Care Setting. Cureus.
Crossref
Crossref
Rüdiger E. Scharf. (2021) Thrombocytopenia and Hemostatic Changes in Acute and Chronic Liver Disease: Pathophysiology, Clinical and Laboratory Features, and Management. Journal of Clinical Medicine 10:7, pages 1530.
Crossref
Crossref
Minodora Onisai, Ana Maria Vlădăreanu, Iuliana Iordan, Cristina Enache, Ovidiu Calapod, Andreea Marin, Carmen Georgeta Fierbinţeanu-Braticevici & Laura Tribus. (2021) Hematological alterations in hepatic cirrhosis – a challenge in clinical practice. Oncolog-Hematolog.ro 1:54, pages 36.
Crossref
Crossref
Naohisa Wada, Haruki Uojima, Takashi Satoh, Sosei Okina, Shuichiro Iwasaki, Xue Shao, Hayato Takiguchi, Yoshitaka Arase, Norio Itokawa, Masanori Atsukawa, Koji Miyazaki, Hisashi Hidaka, Makoto Kako, Tatehiro Kagawa, Katsuhiko Iwakiri, Ryouichi Horie, Takahiro Suzuki & Wasaburo Koizumi. (2021) Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver Disease. Digestive Diseases 39:3, pages 234-242.
Crossref
Crossref
Muhammad Hafiz Kamarul Bahrin, Harini Vijayenthiran, Laura Stimson & Humayun Ahmad. (2020) Persistent Immune Thrombocytopenia Resistant to Immunosuppressive Therapy: What Is the Way Forward?. Cureus.
Crossref
Crossref
Varuni Gunathilake, Marco Bertolino, Giorgio Bavestrello & Preethi Udagama. (2020) Immunomodulatory Activity of the Marine Sponge, Haliclona (Soestella) sp. (Haplosclerida: Chalinidae), from Sri Lanka in Wistar Albino Rats: Immunosuppression and Th1-Skewed Cytokine Response. Journal of Immunology Research 2020, pages 1-11.
Crossref
Crossref
Neta Gotlieb, Naama Schwartz, Shira Zelber-Sagi, Gabriel Chodick, Varda Shalev & Oren Shibolet. (2020) Longitudinal decrease in platelet counts as a surrogate marker of liver fibrosis. World Journal of Gastroenterology 26:38, pages 5849-5862.
Crossref
Crossref
Yaocheng Chen, Ning Cai, Yongrong Lai, Weiwei Xu, Jinyan Li, Lan Huang, Ying Huang, Meiling Hu, Huangju Yang & Jiangming Chen. (2020) Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia. Frontiers in Pharmacology 11.
Crossref
Crossref
Sara Ghoneim, Muhammad Umer Butt, Sophie Trujillo & Imad Asaad. (2020) FIB-4 Regression With Direct-Acting Antiviral Therapy in Patients With Hepatitis C Infection: A Safety-Net Hospital Experience. Frontiers in Medicine 7.
Crossref
Crossref
Marie-Astrid van Dievoet, Stéphane Eeckhoudt & Xavier Stephenne. (2020) Primary Hemostasis in Chronic Liver Disease and Cirrhosis: What Did We Learn over the Past Decade?. International Journal of Molecular Sciences 21:9, pages 3294.
Crossref
Crossref
Silvia Sovaila, Adrian Purcarea, Jean Pierre Fauchart, Dan Gheonea & Tudorel Ciurea. (2020) Hyaluronic Acid, Spleen Size and Prothrombin Time Predict the Existence of High-Risk Esophageal Varices in Non-Viral Cirrhosis in Real Life. Internal Medicine 17:1, pages 7-19.
Crossref
Crossref
Fred Poordad, Norah A. Terrault, Naim Alkhouri, Wei Tian, Lee F. Allen & Mordechai Rabinovitz. (2020) Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 Studies. International Journal of Hepatology 2020, pages 1-11.
Crossref
Crossref
Subramaniam Arulvijayavani, Anbalagan Anithasri & Sivaneshan Harini. (2019) COMPARISON OF NON-INVASIVE FIBROSIS SCORES BETWEEN ALCOHOLIC LIVER DISEASE PATIENTS AND HEALTHY NON-ALCOHOLICS IN SOUTH INDIAN POPULATION. Journal of Evidence Based Medicine and Healthcare 6:31, pages 2084-2088.
Crossref
Crossref
Chunlu Li, Xiaoxuan Li, Feihong Huang, Jing Yang, Anguo Wu, Long Wang, Dalian Qin, Wenjun Zou & Jianming Wu. (2019) Efficacy and Safety of Avatrombopag in Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in Pharmacology 10.
Crossref
Crossref
Liz Ryan. (2019) Procedural Risk of Bleeding: Does the Management of Thrombocytopenia in Chronic Liver Disease Patients Make a Difference? A Debate. EMJ Hepatology, pages 30-38.
Crossref
Crossref
Haruki Uojima, Yoshitaka Arase, Norio Itokawa, Masanori Atsukawa, Takashi Satoh, Koji Miyazaki, Hisashi Hidaka, Ji Hyun Sung, Makoto Kako, Kota Tsuruya, Tatehiro Kagawa, Katsuhiko Iwakiri, Ryouichi Horie & Wasaburo Koizumi. (2018) Relationship between response to lusutrombopag and splenic volume. World Journal of Gastroenterology 24:46, pages 5271-5279.
Crossref
Crossref
Pustika Amalia Wahidiyat, Stephen Diah Iskandar, Novie Amelia Chozie & Damayanti Sekarsari. (2018) Hemostatic abnormalities in children with thalassemia major and liver iron overload. Paediatrica Indonesiana 58:4, pages 175-9.
Crossref
Crossref
Hai-Mei Zhao, Xiao-Yun Zhang, Xiu-Yun Lu, Song-Ren Yu, Xin Wang, Yong Zou, Zheng-Yun Zuo, Duan-Yong Liu & Bu-Gao Zhou. (2018) Erzhi Pill® Protected Experimental Liver Injury Against Apoptosis via the PI3K/Akt/Raptor/Rictor Pathway. Frontiers in Pharmacology 9.
Crossref
Crossref
Romeo-Gabriel Mihăilă. (2017) A Look at Platelet Count in Chronic Hepatitis C Infection. EMJ Hepatology, pages 97-103.
Crossref
Crossref